Insiders Were Right: HALO Makes New 52-Week High
March 04, 2015 at 16:07 PM EST
In trading on Wednesday, shares of Halozyme Therapeutics Inc (HALO) touched a new 52-week high of $15.94/share. That's a 131.69% rise, or $9.06 per share from the 52-week low of $6.88 set back on 04/28/2014..
